πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 58 of 78

  1. US 7557196

    hGC-1, a gene encoding a member of the olfactomedin-related protein family

    Expires Mon Jul 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7553490

    Vaccines against Escherichia coli O157 infection

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7553936

    Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

    Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7550275

    Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide

    Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7547773

    Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7547762

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7547712

    Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

    Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7544713

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7544789

    DNA encoding Toxoplasma gondii rDGP5p protein

    Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7544778

    Recombinant antigens for diagnosis and prevention of murine typhus

    Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7541040

    Chimeric molecule for the treatment of th2-like cytokine mediated disorders

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7541139

    Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7541043

    Vaccine for protection against Shigella sonnei disease

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7541035

    Immunogenic peptides for the treatment of prostate and breast cancer

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7541034

    Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

    Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7537765

    Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7534565

    DLC-1 gene deleted in cancers

    Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7531635

    MATER-protein specific antibodies and methods of use

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7531352

    Inducible plasmid vector encoding TGF-Ξ² and use thereof

    Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7528274

    Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7527797

    Vibrio cholerae 0139 conjugate vaccines

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7527802

    Vaccine for transcutaneous immunization

    Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7524508

    Subgenomic replicons of the flavivirus dengue

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7524516

    Corrosion inhibiting mildew remover kit

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7524507

    Recombinant microorganisms

    Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7521475

    Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7521063

    Multiple CPG oligodeoxynucleotides and their use to induce an immune response

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7521054

    Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7521177

    Flavivirus detection methods employing recombinant antigens comprising a Japanese encephalitis (JEV) signal sequence

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7521479

    Methods of treating prion disease in mammals

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7517849

    Inhibition of ABC transporters by transmembrane domain analogs

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7517527

    Immunotoxin with in vivo T cell suppressant activity and methods of use

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7517531

    Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

    Expires Mon Apr 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7514415

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7514529

    Peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccines

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7514414

    Suppressors of CpG oligonucleotides and methods of use

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7511032

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7510715

    Protozoan derived compositions and methods of use thereof

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7511015

    Modified defensins and their use

    Expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7507538

    Human papilloma virus immunoreactive peptides

    Expires Mon Mar 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7504430

    Maleiimide anti-tumor phosphatase inhibitors

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7504109

    Influenza hemagglutinin and neuraminidase variants

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7504096

    Methods for in vitro fertilization

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7504243

    Methods for the production of biliverdin

    Expires Mon Mar 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7501132

    Multiple antigenic peptides immunogenic against Streptococcus pneumonia

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7501494

    Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7501501

    MHC-Class II restricted melanoma antigens and their use in therapeutic methods

    Expires Mon Mar 05 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7498336

    Deazaflavin compounds and methods of use thereof

    Expires Mon Feb 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.